This article is brought to you in association with the European Commission. The European Commission has approved, under the EU Merger Regulation, the proposed merger between the global pharmaceutical company Mylan and Upjohn, a business division of Pfizer, which operates Pfizer’s off-patent branded and generic established medicines. The decision is conditional on the divestment of Mylan’s […]Mergers: Commission approves the merger of Mylan and Pfizer’s Upjohn division, subject to conditions
April 23, 2020 by Leave a Comment
This article is brought to you in association with the European Commission. The European Commission has approved, under the EU Merger Regulation, the proposed merger between the global pharmaceutical company Mylan and Upjohn, a business division of Pfizer, which operates Pfizer’s off-patent branded and generic established medicines. The decision is conditional on the divestment of Mylan’s […]
